Which Detector Do You Need for GLP-1RAs? Choosing Between MALS and Mass Spec
This webinar explains how multi-angle light scattering (MALS) and mass spectrometry (MS) provide complementary insights into GLP-1RA quality.
RECORD
|
Already taken place Tu, 16.6.2026
Tu, 16.6.2026
Waters Corporation
Is your Biosimilar, Similar?
Explore regulatory expectations and advanced SEC-MALS workflows for biosimilarity assessment of monoclonal antibodies, including CQAs, aggregation analysis, and impurity profiling.
RECORD
|
Already taken place Th, 28.5.2026
Th, 28.5.2026
Waters Corporation
Reliable GLP-1 Aggregate Analysis Using Biozen dSEC
This webinar provides an exploration of peptide aggregation mechanisms and how SEC can be applied to characterize these critical quality attributes.
RECORD
|
Already taken place We, 27.5.2026
We, 27.5.2026
Phenomenex
Beyond Surface Separation: Navigating Mega Molecule Sizing with Wide Pore SEC-MALS
Understand how pore structure impacts SEC separations of large biomolecules. Learn how SEC-MALS enables accurate sizing, aggregation analysis, and robust method development.
RECORD
|
Already taken place We, 20.5.2026
We, 20.5.2026
Waters Corporation
Size variant analysis of antibodies and ADCs using SEC, SEC-MALS, SEC-MS, and 2D Protein A-SEC Methods
Size‑exclusion chromatography (SEC) is essential for analyzing aggregates, monomers, and fragments in biotherapeutic proteins.
RECORD
|
Already taken place Tu, 12.5.2026
Tu, 12.5.2026
Waters Corporation
Fundamentals First Bio Series – SEC for Biologics
Master SEC fundamentals for biopharma—covering principles, column selection, and troubleshooting with real-world applications in mAbs, AAVs, and nucleic acids.
RECORD
|
Already taken place We, 29.4.2026
We, 29.4.2026
Phenomenex
Tosoh Tuesday - What is MALS & When is it Useful?
Join Tosoh Tuesday to explore MALS fundamentals, practical implementation, and real-world SEC-MALS applications for polymer and biologics characterization.
RECORD
|
Already taken place Tu, 28.4.2026
Tu, 28.4.2026
Tosoh Bioscience
Navigating Regulatory Guidance for LNP and Liposomal Drug Characterization Using FFF-MALS
Learn how FFF-MALS enables comprehensive characterization of lipid nanoparticles and liposomes, supporting regulatory-relevant CQAs such as size, morphology, and encapsulation efficiency.
RECORD
|
Already taken place We, 25.3.2026
We, 25.3.2026
Waters Corporation
From Raw Materials to Conjugation Sites: Advanced LC, MS and MALS Strategies for AOC Characterization and Monitoring
This webinar explores the comprehensive analysis of Antibody Oligonucleotide Conjugates (AOCs) using LC-MS and LC-MALS.
RECORD
|
Already taken place Th, 5.3.2026
Th, 5.3.2026
Waters Corporation
Leveraging SEC-MALS for Regulatory-Aligned Biosimilarity Assessment
Learn how SEC-MALS supports confident biosimilar comparability by accurately characterizing molecular weight, aggregation, and key CQAs in line with FDA and ICH Q6B guidance.
RECORD
|
Already taken place Th, 26.2.2026
Th, 26.2.2026
Waters Corporation
Related content
Webinars LabRulezLCMS Week 34/2026
Mo, 17.8.2026
LabRulez
An Analyte-Specific LC-IMS-HRMS Framework for Enhanced Identification Confidence in Target Screening of Contaminants in Complex Matrices
Mo, 17.8.2026
LabRulez
LC-MS Metabolomics and Next-Generation Ionization Technologies